Friday, December 21, 2012 11:05:09 AM
Chembio Diagnostics receives FDA approval for DPP Point-of-Care HIV 1/2 rapid test (CEMI) 4.60 : Co announces receipt of approval from the FDA to market the Company's Dual Path Platform HIV 1/2 assay for the rapid, point-of-care (POC) detection of HIV-1/2 antibodies in either oral fluid or blood samples. This determination follows a review of Chembio's Premarket Approval application and marks the first FDA approval of a diagnostic assay utilizing the Company's patented Dual Path Platform? technology. DPP enables samples to bind directly with target analytes before detection reagents are introduced to visualize the test results, and can improve accuracy compared with the current lateral flow HIV test technologies.
Recent CEMI News
- Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer • PR Newswire (US) • 10/17/2023 09:00:00 AM
- Biosynex Completes Acquisition of Chembio Diagnostics, Inc. • GlobeNewswire Inc. • 04/27/2023 08:30:00 PM
- Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023 • GlobeNewswire Inc. • 04/19/2023 12:00:00 PM
- Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc. • GlobeNewswire Inc. • 04/13/2023 11:00:00 AM
- Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023 • GlobeNewswire Inc. • 04/10/2023 12:00:00 PM
- Chembio’s CEO Letter to Stockholders • GlobeNewswire Inc. • 04/03/2023 08:15:00 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM